|
Dr. Keim brings more than 39 years of research and discovery, clinical research, and regulatory experience to Clinilabs. He currently is the Chief Development Officer of INC Research, Inc. Dr. Keim’s former positions include his roles as President and CEO of Vela Pharmaceuticals Inc. and President of Quintiles Pacific, Inc., where he provided executive leadership and directive consultative solutions in the global CNS therapeutics market. His formative years in the pharmaceutical industry were spent at Hoffmann-La Roche and Wyeth. Dr. Keim currently sits on the boards of directors of the American Society of Experimental NeuroTherapeutics (ASENT), NeuroMedix, Inc., and the Affiliated Research Institute. He received his doctoral degree from New York University and his Masters of Science degree from Fairleigh Dickinson University. Dr. Keim’s undergraduate work was conducted at Delaware Valley College. | 